Larkspur Biosciences Announces Discovery of LRK-4189 For Treatment Of Microsatellite Stable (MSS) Colorectal Cancer
Aug 20 (Reuters) - Larkspur Biosciences:
LARKSPUR BIOSCIENCES ANNOUNCES DISCOVERY OF LRK-4189, A FIRST-IN-CLASS DEGRADER OF THE LIPID KINASE PIP4K2C, FOR THE TREATMENT OF MICROSATELLITE STABLE (MSS) COLORECTAL CANCER AT THE ACS FALL 2025 MEETING
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.